Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phillip M. Devlin, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Comparison of two dose-fractionation schemes in toxicity, efficacy, and cosmesis for early stage, low risk breast cancer patients undergoing MammoSite accelerated partial breast irradiation
Summer, 06/16/08 - 12/19/08
Family Hisotry, TP53, and MDM2 in Childhood Cancer Survivors
Summer, 06/18/07 - 08/10/07

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Fefer M, Lamb CC, Shen AH, Clardy P, Muralidhar V, Devlin PM, Dee EC. Multilingual Analysis of the Quality and Readability of Online Health Information on the Adverse Effects of Breast Cancer Treatments. JAMA Surg. 2020 Jun 10. PMID: 32520317.
    Citations:    
  2. Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations. Cancer. 2020 09 01; 126(17):3900-3906. PMID: 32478867.
    Citations:    
  3. Dee EC, Fefer M, Hammoudeh L, Yu Z, Cantalino JM, Johnson TJ, O'Farrell DA, Bui AN, Muralidhar V, Mahal BA, Nguyen PL, LeBoeuf NR, Devlin PM. Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparison. J Am Acad Dermatol. 2020 Apr 19. PMID: 32320768.
    Citations:    
  4. Kim DW, Buzurovic IM, Mahal BV, Hwang W, Oladeru OT, O'Farrell DA, Harris TC, Margalit DN, Lam M, Devlin PM. Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand. J Contemp Brachytherapy. 2020 Feb; 12(1):48-52. PMID: 32190070.
    Citations:    
  5. Likhacheva A, Petit JH, Zaky S, Devlin PM. In Reply to the American Academy of Dermatology Letter Regarding: Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: An American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2020 May - Jun; 10(3):211-212. PMID: 32035246.
    Citations:    
  6. Guthier CV, Devlin PM, Harris TC, O'Farrell DA, Cormack RA, Buzurovic I. Development and clinical implementation of semi-automated treatment planning including 3D printable applicator holders in complex skin brachytherapy. Med Phys. 2020 Mar; 47(3):869-879. PMID: 31855280.
    Citations:    
  7. Likhacheva A, Awan M, Barker CA, Bhatnagar A, Bradfield L, Brady MS, Buzurovic I, Geiger JL, Parvathaneni U, Zaky S, Devlin PM. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline. Pract Radiat Oncol. 2020 Jan - Feb; 10(1):8-20. PMID: 31831330.
    Citations:    
  8. Mooney MA, Bi WL, Cantalino JM, Wu KC, Harris TC, Possatti LL, Juvekar P, Hsu L, Dunn IF, Al-Mefty O, Devlin PM. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020 Jan; 146(1):111-120. PMID: 31745706.
    Citations:    
  9. O'Malley JT, de Masson A, Lowry EL, Giobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res. 2020 01 15; 26(2):408-418. PMID: 31636100.
    Citations:    
  10. Otter SJ, Stewart AJ, Devlin PM. Modern Brachytherapy. Hematol Oncol Clin North Am. 2019 12; 33(6):1011-1025. PMID: 31668203.
    Citations:    
  11. Bitterman DS, Sanford NN, Niemierko A, Mahal BA, Qadan M, Ganguli S, Blaszkowsky LS, Zhu AX, Hong TS, Devlin PM, Goyal L, Wo JY. Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis. Am J Clin Oncol. 2019 07; 42(7):564-572. PMID: 31166209.
    Citations:    
  12. King MT, Yang DD, Muralidhar V, Mahal B, Butler S, Devlin PM, Lee LJ, Mouw KW, Martin NM, D'Amico AV, Nguyen PL, Orio PF. A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer. Brachytherapy. 2019 Mar - Apr; 18(2):186-191. PMID: 30638912.
    Citations:    Fields:    
  13. de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS. High-throughput sequencing of the T cell receptor ß gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med. 2018 05 09; 10(440). PMID: 29743350.
    Citations:    Fields:    
  14. King MT, Chen MH, Moran BJ, Braccioforte MH, Buzurovic I, Muralidhar V, Yang DD, Mouw KW, Devlin PM, D'Amico AV, Nguyen PL, Orio PF. Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer. Urol Oncol. 2018 04; 36(4):157.e15-157.e20. PMID: 29276060.
    Citations:    Fields:    Translation:Humans
  15. Devlin PM, Gaspar LE, Buzurovic I, Demanes DJ, Kasper ME, Nag S, Ouhib Z, Petit JH, Rosenthal SA, Small W, Wallner PE, Hartford AC. American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources. Brachytherapy. 2017 Nov - Dec; 16(6):1083-1090. PMID: 28988661.
    Citations:    Fields:    Translation:Humans
  16. Yang DD, Muralidhar V, Mahal BA, Nguyen PL, Devlin PM, King MT, Orio PF. Lack of Apparent Survival Benefit With Use of Androgen Deprivation Therapy in Patients With High-risk Prostate Cancer Receiving Combined External Beam Radiation Therapy and Brachytherapy. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):53-58. PMID: 29254781.
    Citations: 1     Fields:    Translation:Humans
  17. Yang DD, Muralidhar V, Nguyen PL, Buzurovic I, Martin NE, Mouw KW, Devlin PM, Trinh QD, Orio PF, King MT. Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):904-911. PMID: 29063853.
    Citations: 1     Fields:    Translation:Humans
  18. Aldelaijan S, Bekerat H, Buzurovic I, Devlin P, DeBlois F, Seuntjens J, Devic S. Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions. Brachytherapy. 2017 Sep - Oct; 16(5):1065-1072. PMID: 28735877.
    Citations: 1     Fields:    Translation:Humans
  19. Buzurovic IM, O'Farrell DA, Bhagwat MS, Hansen JL, Harris TC, Friesen S, Cormack RA, Devlin PM. Custom-made micro applicators for high-dose-rate brachytherapy treatment of chronic psoriasis. J Contemp Brachytherapy. 2017 Jun; 9(3):263-269. PMID: 28725251.
    Citations:    
  20. Mangione FM, Jatene T, Badr Eslam R, Bergmark BA, Gallagher JR, Shah PB, Mauri L, Leopold JA, Sobieszczyk PS, Faxon DP, Croce KJ, Bhatt DL, Devlin PM. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. Am J Cardiol. 2017 Aug 01; 120(3):369-373. PMID: 28583681.
    Citations:    Fields:    Translation:Humans
  21. Pinard J, Vleugels RA, Kurtzman DJ, Devlin PM, Patel M. Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau. JAMA Dermatol. 2017 04 01; 153(4):331-332. PMID: 28122079.
    Citations:    Fields:    Translation:Humans
  22. Damato AL, Buzurovic I, Bhagwat MS, Cormack RA, Devlin PM, Friesen S, Hansen J, Lee LJ, Manuel MM, Cho LP, O'Farrell D, Viswanathan AN. The value of systematic contouring of the bowel for treatment plan optimization in image-guided cervical cancer high-dose-rate brachytherapy. Brachytherapy. 2017 May - Jun; 16(3):579-585. PMID: 28256433.
    Citations:    Fields:    Translation:Humans
  23. Ho KJ, Devlin PM, Madenci AL, Semel ME, Gravereaux EC, Nguyen LL, Belkin M, Menard MT. High dose-rate brachytherapy for the treatment of lower extremity in-stent restenosis. J Vasc Surg. 2017 03; 65(3):734-743. PMID: 27986482.
    Citations:    Fields:    Translation:Humans
  24. Likhacheva AO, Devlin PM, Shirvani SM, Barker CA, Beron P, Bhatnagar A, Doggett SW, Hochman L, Hsu C, Kasper M, Keisch M, Mutyala S, Prestidge B, Rodriguez Villalba S, Shukla V, Sundararaman S, Kamrava M. Skin surface brachytherapy: A survey of contemporary practice patterns. Brachytherapy. 2017 Jan - Feb; 16(1):223-229. PMID: 27908679.
    Citations: 2     Fields:    Translation:Humans
  25. Cho LP, Manuel M, Catalano P, Lee L, Damato AL, Cormack RA, Buzurovic I, Bhagwat M, O'Farrell D, Devlin PM, Viswanathan AN. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience. Gynecol Oncol. 2016 Dec; 143(3):545-551. PMID: 27720445.
    Citations:    Fields:    Translation:Humans
  26. Buzurovic IM, Hansen JL, Bhagwat MS, O'Farrell DA, Friesen S, Harris TC, Damato AL, Cormack RA, Martin NE, Devlin PM. Clinical implementation of a novel applicator in high-dose-rate brachytherapy treatment of esophageal cancer. J Contemp Brachytherapy. 2016 Aug; 8(4):319-25. PMID: 27648086.
    Citations: 2     
  27. Paul S, Bach D, LeBoeuf NR, Devlin PM, Lipworth AD. Successful use of brachytherapy for a severe hidradenitis suppurativa variant. Dermatol Ther. 2016 Nov; 29(6):455-458. PMID: 27425163.
    Citations:    Fields:    Translation:Humans
  28. Damato A, Devlin P, Bhagwat M, Buzurovic I, Hansen J, O'Farrell D, Cormack R. WE-DE-201-11: Sensitivity and Specificity of Verification Methods Based On Total Reference Air Kerma (TRAK) Or On User Provided Dose Points for Graphically Planned Skin HDR Brachytherapy. Med Phys. 2016 Jun; 43(6):3810-3811. PMID: 28048473.
    Citations:    
  29. Buzurovic I, Devlin P, Hansen J, O'Farrell D, Bhagwat M, Friesen S, Damato A, Harris T, Cormack R. SU-G-201-04: Can the Dynamic Library of Flap Applicators Replace Treatment Planning in Surface Brachytherapy? Med Phys. 2016 Jun; 43(6):3623. PMID: 28047025.
    Citations:    
  30. Timerman D, Devlin PM, Nambudiri VE, Wright NA, Vleugels RA, Clark RA, Kupper TS, Merola JF, Patel M. Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis. Clin Exp Dermatol. 2016 Jul; 41(5):498-501. PMID: 26848819.
    Citations:    Fields:    Translation:Humans
  31. Goddard AL, Vleugels RA, LeBoeuf NR, O'Farrell DA, Cormack RA, Hansen JL, Kupper TS, Devlin PM. Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. JAMA Dermatol. 2015 Dec 01; 151(12):1354-1357. PMID: 26397774.
    Citations: 3     Fields:    
  32. Stewart A, Parashar B, Patel M, O'Farrell D, Biagioli M, Devlin P, Mutyala S. American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. Brachytherapy. 2016 Jan-Feb; 15(1):1-11. PMID: 26561277.
    Citations: 3     Fields:    Translation:Humans
  33. Abou Al-Shaar H, Almefty KK, Abolfotoh M, Arvold ND, Devlin PM, Reardon DA, Loeffler JS, Al-Mefty O. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas. J Neurooncol. 2015 Sep; 124(3):515-22. PMID: 26253325.
    Citations:    Fields:    Translation:Humans
  34. Wagar M, Bhagwat M, O'Farrell D, Friesen S, Buzurovic I, Damato A, Devlin P, Cormack R. SU-E-T-413: Examining Acquisition Rate for Using MatriXX Ion Chamber Array to Measure HDR Brachytherapy Treatments. Med Phys. 2015 Jun; 42(6):3429. PMID: 26128080.
    Citations:    
  35. Buzurovic I, Hansen J, Bhagwat M, O'Farrell D, Damato A, Friesen S, Devlin P, Cormack R. SU-E-T-165: Characterization of Dose Distributions in High-Dose-Rate Surface Brachytherapy. Med Phys. 2015 Jun; 42(6):3369. PMID: 26127828.
    Citations:    
  36. Sugar EN, Buzurovic I, O'Farrell D, Hansen J, Devlin P, Cormack R, Nguyen P. SU-E-T-301: Dosimetric Comparison Between Adaptive and Rectilinear Template-Based Prostate Seed Implants. Med Phys. 2015 Jun; 42(6):3402. PMID: 26127964.
    Citations:    
  37. Bhagwat M, O'Farrell D, Wagar M, Buzurovic I, Friesen S, Damato A, Devlin P, Cormack R. SU-E-T-783: Using Matrixx to Determine Transit Dose Contribution Over Clinically Useful Limits of HDR Source Activity. Med Phys. 2015 Jun; 42(6):3517. PMID: 26128445.
    Citations:    
  38. Muralidhar V, Mahal BA, Ziehr DR, Chen YW, Nezolosky MD, Viswanathan VB, Beard CJ, Devlin PM, Martin NE, Orio PF, Nguyen PL. Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. Brachytherapy. 2015 Jul-Aug; 14(4):511-6. PMID: 25887342.
    Citations: 1     Fields:    Translation:Humans
  39. Lane JD, Pomahac B, Raut CP, Baldini EH, Devlin PM. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229. PMID: 25426346.
    Citations: 1     
  40. Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63. PMID: 25341749.
    Citations: 3     Fields:    Translation:Humans
  41. Damato AL, Devlin PM, Bhagwat MS, Buzurovic I, Friesen S, Hansen JL, Lee LJ, Molodowitch C, Nguyen PL, O'Farrell DA, Viswanathan AN, Williams CL, Killoran JH, Cormack RA. Independent brachytherapy plan verification software: improving efficacy and efficiency. Radiother Oncol. 2014 Dec; 113(3):420-4. PMID: 25458129.
    Citations: 4     Fields:    Translation:Humans
  42. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr TR, Suh WW, Devlin PM, Tempany CM, Sugar EH, O'Farrell DA, Steele G, O'Leary M, Buzurovic I, Damato AL, Cormack RA, Fedorov AY, Nguyen PL. Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. Radiat Oncol. 2014 Sep 09; 9:200. PMID: 25205146.
    Citations: 2     Fields:    Translation:Humans
  43. Buzurovic I, Devlin P, Hansen J, O' Farrell D, Bhagwat M, Friesen S, Damato A, Lewis J, Cormack R. SU-E-T-362: Automatic Catheter Reconstruction of Flap Applicators in HDR Surface Brachytherapy. Med Phys. 2014 Jun; 41(6):308. PMID: 28037929.
    Citations:    
  44. Damato AL, Bhagwat MS, Buzurovic I, Devlin PM, Friesen S, Hansen JL, Kapur T, Lee LJ, Mehrtash A, Nguyen PL, O' Farrell D, Wang W, Viswanathan AN, Cormack RA. WE-A-17A-03: Catheter Digitization in High-Dose-Rate Brachytherapy with the Assistance of An Electromagnetic (EM) Tracking System. Med Phys. 2014 Jun; 41(6):487-488. PMID: 28037155.
    Citations:    
  45. Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Brachytherapy. 2014 Sep-Oct; 13(5):442-9. PMID: 24880584.
    Citations: 4     Fields:    Translation:Humans
  46. Nguyen PL, Hyatt AS, Devlin PM. PSA screening: the case in favor. Oncology (Williston Park). 2013 Oct; 27(10):980, 982. PMID: 24367854.
    Citations:    Fields:    Translation:Humans
  47. Stewart AJ, Hepel JT, O'Farrell DA, Devlin PM, Price LL, Dale RG, Wazer DE. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Radiother Oncol. 2013 Aug; 108(2):232-5. PMID: 23891101.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  48. Garibyan L, Cotter SE, Hansen JL, Noell C, Dorosario A, O'Farrell DA, Devlin PM, Wang LC. Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J. 2013 Jul-Aug; 19(4):283-7. PMID: 23867506.
    Citations: 4     Fields:    Translation:Humans
  49. DeSimone JA, Guenova E, Carter JB, Chaney KS, Aldridge JR, Noell CM, Dorosario AA, Hansen JL, Kupper TS, Devlin PM. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2013 Jul; 69(1):61-5. PMID: 23453243.
    Citations: 2     Fields:    Translation:Humans
  50. Holloway CL, Delaney TF, Alektiar KM, Devlin PM, O'Farrell DA, Demanes DJ. American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy. 2013 May-Jun; 12(3):179-90. PMID: 23434220.
    Citations: 11     Fields:    Translation:Humans
  51. McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7. PMID: 23392853.
    Citations: 11     Fields:    Translation:Humans
  52. Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9. PMID: 23242820.
    Citations: 13     Fields:    Translation:Humans
  53. Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR. Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 01; 85(2):355-62. PMID: 23040221.
    Citations: 3     Fields:    Translation:Humans
  54. Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. Brachytherapy. 2013 Jan-Feb; 12(1):19-24. PMID: 22819388.
    Citations: 1     Fields:    Translation:Humans
  55. Nguyen PL, Devlin PM, Beard CJ, Orio PF, O'Leary MP, Wolfsberger LD, O'Farrell DA, Sweeney CM, Hadaschik BA, Hohenfellner M, Hatiboglu G. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 2013 Jan-Feb; 12(1):77-83. PMID: 22543116.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  56. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr T, Suh WW, Devlin PM, Tempany CM, Nguyen PL. Variability in prostate volume as determined by MRI versus ultrasound and its impact on treatment recommendations for patients with favorable-risk prostate cancer. J Clin Oncol. 2012 Feb 10; 30(5_suppl):249. PMID: 28143244.
    Citations:    
  57. Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Arch Dermatol. 2011 Jul; 147(7):870-2. PMID: 21768497.
    Citations: 13     Fields:    Translation:Humans
  58. Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):e813-8. PMID: 21300455.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  59. Cotter SE, Devlin PM, Sahni D, Hansen JL, O'Farrell DA, Ng AK, Wang LC. Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. J Clin Oncol. 2010 Sep 20; 28(27):e464-6. PMID: 20679604.
    Citations: 5     Fields:    Translation:Humans
  60. Ahmed HM, Dipiro PJ, Devlin PM, Nguyen ML, Bellon JR. Mammographic appearance following accelerated partial breast irradiation by using MammoSite brachytherapy. Radiology. 2010 May; 255(2):362-8. PMID: 20332376.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  61. Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 2010 May; 83(989):369-78. PMID: 20223911.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  62. Stewart AJ, Devlin PM, Mutyala S. Counterpoint: the dose rate argument--Does size matter after all? Brachytherapy. 2009 Jul-Sep; 8(3):273-5. PMID: 19643374.
    Citations:    Fields:    Translation:Humans
  63. Mutyala S, Devlin PM, Stewart AJ. Rebuttal to Drs. Davidson, Hendry, and West: once burned, twice shy? Brachytherapy. 2009 Jul-Sep; 8(3):277. PMID: 19643376.
    Citations:    Fields:    Translation:Humans
  64. Mutyala S, Stewart A, Khan AJ, Cormack RA, O'Farrell D, Sugarbaker D, Devlin PM. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1114-20. PMID: 19540065.
    Citations: 3     Fields:    Translation:Humans
  65. Siddiqi NH, Devlin PM. Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report. J Vasc Interv Radiol. 2009 May; 20(5):664-9. PMID: 19328722.
    Citations: 1     Fields:    Translation:Humans
  66. Stewart AJ, Mutyala S, Holloway CL, Colson YL, Devlin PM. Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. Brachytherapy. 2009 Jan-Mar; 8(1):63-9. PMID: 19056322.
    Citations: 4     Fields:    Translation:Humans
  67. Stewart AJ, O'Farrell DA, Cormack RA, Hansen JL, Khan AJ, Mutyala S, Devlin PM. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008 Nov 19; 3:39. PMID: 19019216.
    Citations: 10     Fields:    Translation:Humans
  68. Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM. Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):323-6. PMID: 18793951.
    Citations:    Fields:    
  69. Siddiqi NH, Khan AJ, Devlin PM. Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study. Cardiovasc Intervent Radiol. 2009 Jan; 32(1):47-51. PMID: 18779994.
    Citations:    Fields:    Translation:Humans
  70. Cormack RA, Devlin PM. Brachytherapy partial breast irradiation: analyzing effect of source configurations on dose metrics relevant to toxicity. Int J Radiat Oncol Biol Phys. 2008 Jul 01; 71(3):940-4. PMID: 18514786.
    Citations: 1     Fields:    Translation:PHPublic Health
  71. Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatr Scand. 2008 Apr; 117(4):271-6. PMID: 18307587.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  72. Cormack RA, Holloway CL, O'Farrell D, Devlin PM. Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1310-5. PMID: 17967321.
    Citations:    Fields:    Translation:Humans
  73. Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV. Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. Urol Oncol. 2008 Mar-Apr; 26(2):147-52. PMID: 18312933.
    Citations: 3     Fields:    Translation:Humans
  74. Mutyala S, Choi W, Khan AJ, Yaparpalvi R, Stewart AJ, Devlin PM. Inherent change in MammoSite applicator three-dimensional geometry over time. Radiat Oncol. 2007 Sep 24; 2:37. PMID: 17892557.
    Citations:    Fields:    
  75. Rivard MJ, Butler WM, Devlin PM, Hayes JK, Hearn RA, Lief EP, Meigooni AS, Merrick GS, Williamson JF. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy. 2007 Jan-Mar; 6(1):34-7. PMID: 17284383.
    Citations: 6     Fields:    Translation:Humans
  76. Stewart AJ, O'Farrell DA, Mutyala S, Bueno R, Sugarbaker DJ, Cormack RA, Devlin PM. Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. Brachytherapy. 2007 Jan-Mar; 6(1):58-61. PMID: 17284388.
    Citations:    Fields:    Translation:Humans
  77. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, Tempany C. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):91-9. PMID: 16839709.
    Citations: 16     Fields:    Translation:Humans
  78. Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect. 2006 May; 52(5):329-34. PMID: 16176833.
    Citations: 13     Fields:    Translation:Humans
  79. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005 Jul 07; 3:27. PMID: 15987522.
    Citations: 85     Fields:    Translation:HumansCells
  80. Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005 May; 27(5):353-61. PMID: 15726587.
    Citations: 1     Fields:    Translation:Humans
  81. Stewart AJ, O'Farrell DA, Bellon JR, Hansen JL, Duggan C, Czerminska MA, Cormack RA, Devlin PM. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery. Brachytherapy. 2005; 4(3):224-9. PMID: 16182223.
    Citations: 2     Fields:    Translation:Humans
  82. Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up. Am J Clin Oncol. 2004 Aug; 27(4):369-75. PMID: 15289730.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  83. Iftimia I, Devlin PM, Martin AG, Shakur R, Almonacid A, Kazakin J, Chin LM, Cormack RA. Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source. Brachytherapy. 2004; 3(4):215-21. PMID: 15607153.
    Citations:    Fields:    Translation:Humans
  84. Iftimia I, Devlin PM, Chin LM, Baron JM, Cormack RA. GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train. Med Phys. 2003 Jun; 30(6):1004-12. PMID: 12852522.
    Citations:    Fields:    Translation:Humans
  85. Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002 Jun 01; 53(2):394-400. PMID: 12023144.
    Citations: 24     Fields:    Translation:HumansPHPublic Health
  86. Devlin PM, Brus CR, Kazakin J, Mitchell RB, Demanes DJ, Edmundson G, Gribble M, Gustafson GS, Kelly DA, Linares LA, Martinez AA, Mate TP, Nag S, Perez CA, Rao JG, Rodriguez RR, Shasha D, Tripuraneni P. An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):104-15. PMID: 12007948.
    Citations:    Fields:    Translation:Humans
  87. Devlin PM, Harrison LB. Brachytherapy for soft tissue sarcomas. Cancer Treat Res. 1997; 91:107-28. PMID: 9286492.
    Citations:    Fields:    Translation:Humans
  88. Hata S, Clabby M, Devlin P, Spits H, De Vries JE, Krangel MS. Diversity and organization of human T cell receptor delta variable gene segments. J Exp Med. 1989 Jan 01; 169(1):41-57. PMID: 2521243.
    Citations: 27     Fields:    Translation:HumansCells
  89. Hata S, Satyanarayana K, Devlin P, Band H, McLean J, Strominger JL, Brenner MB, Krangel MS. Extensive junctional diversity of rearranged human T cell receptor delta genes. Science. 1988 Jun 10; 240(4858):1541-4. PMID: 3259726.
    Citations: 30     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Devlin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (289)
Explore
_
Co-Authors (106)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.